🇩🇪 BNT162b7 Bivalent (Original/OMI BA.4/BA.5) in Germany

BNT162b7 Bivalent (Original/OMI BA.4/BA.5) (bnt162b7-bivalent-original-omi-ba-4-ba-5) regulatory status in Germany.

Marketing authorisation

BfArM

  • Status: approved

BNT162b7 Bivalent (Original/OMI BA.4/BA.5) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Germany

Frequently asked questions

Is BNT162b7 Bivalent (Original/OMI BA.4/BA.5) approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for BNT162b7 Bivalent (Original/OMI BA.4/BA.5) in Germany?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.